)
David Yang
Partner
Lux Capital
David partners with entrepreneurs and innovators in the life sciences, investing in companies across therapeutics, R&D tools, and biopharma infrastructure.
Prior to Lux, David was the co-founder and Head of Strategy & Ops of Latus Bio - a gene therapy company focused on neurological disorders. David additionally spent 4 years at 8VC investing in therapeutics and life sciences infrastructure companies. His passion for biotech first started at the Broad Institute, where he developed computational and experimental tools for viral diagnostics, whose results were published in Nature and Cell.
Sessions
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}